OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances of Biphenyl Small-Molecule Inhibitors Targeting PD-1/PD-L1 Interaction in Cancer Immunotherapy
Roufen Chen, Dandan Yuan, Junjie Ma
Future Medicinal Chemistry (2021) Vol. 14, Iss. 2, pp. 97-113
Closed Access | Times Cited: 14

Showing 14 citing articles:

Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
Dandan Yuan, Yali Gao, Lin Xia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access

Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025), pp. 101215-101215
Closed Access

A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules
Marialuigia Fantacuzzi, Roberto Paciotti, Mariangela Agamennone
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 316-316
Open Access | Times Cited: 4

Progress in small-molecule inhibitors targeting PD-L1
J. Xu, Yuanfang Kong, Pengbo Zhu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1161-1175
Closed Access | Times Cited: 4

Computational analysis of PD-L1 dimerization mechanism induced by small molecules and potential dynamical properties
Xiaole Xu, Song Luo, Xiaoyu Zhao, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130921-130921
Closed Access | Times Cited: 3

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Xavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3368-3368
Open Access | Times Cited: 11

Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists
Xingye Wu, He Li, Han Liu, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 4, pp. 518-523
Closed Access | Times Cited: 1

A Potential Off-Target Effect of the Wnt/β-Catenin Inhibitor KYA1797K: PD-L1 Binding and Checkpoint Inhibition
Xavier Thuru, Romain Magnez, Gérard Vergoten, et al.
Biomedicine Hub (2023) Vol. 8, Iss. 1, pp. 1-9
Open Access | Times Cited: 4

Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design
Greta Donati, Vincenzo Maria D’Amore, Pasquale Russomanno, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 3355-3368
Open Access | Times Cited: 4

Biphenyls in Clusiaceae: Isolation, structure diversity, synthesis and bioactivity
Youyi Wang, Qing Huang, Li Zhang, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 6

Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents
Natascha Leleu‐Chavain, Romain Regnault, Hania Ahouari, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3316-3316
Open Access | Times Cited: 4

Synthesis and immunotherapy efficacy of a PD-L1 small-molecule inhibitor combined with its 131I-iodide labelled isostructural compound
Gao‐Chao Lv, Xin Hu, Nan Zhang, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107810-107810
Closed Access

Design, synthesis, and anti-breast tumor activity of novel combretastatin A-4 analogues
Yiting Gao, Jinfang Li, Teng Ma
Monatshefte für Chemie - Chemical Monthly (2023) Vol. 154, Iss. 11, pp. 1285-1294
Closed Access

Page 1

Scroll to top